Literature DB >> 30976824

[Modern concepts for the dynamic preservation of the liver and kidneys in the context of transplantation].

C von Horn1, T Minor2.   

Abstract

The increasing demand on donor grafts has forced experimental research on transplantation medicine to develop more efficient organ preservation strategies. Simple cold storage of grafts rarely offers optimal conditions for extended criteria donor organs. Hypothermic, oxygenated machine perfusion (HMP) is a classical method of dynamic organ preservation, which enables the provision of oxygen and nutrients to the tissue and provides a metabolic recovery of the graft prior to implantation. A more modern approach is normothermic machine perfusion (NMP), which instead simulates physiological conditions and enables an ex vivo evaluation and treatment of organ grafts. However, studies have found that a preceding period of cold storage significantly mitigates the functional advantage of NMP. A strategy to circumvent this phenomenon is controlled oxygenated rewarming (COR). The cold-stored graft is slowly and gradually rewarmed to subnormothermic or normothermic temperatures, providing a gentle adaption of energy metabolism and counteracting events of rewarming injury.

Entities:  

Keywords:  Bretschneider cardioplegic solution; Cold ischemia; Organ preservation; Organ transplantation; Perfusion

Mesh:

Year:  2019        PMID: 30976824     DOI: 10.1007/s00292-019-0595-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  2 in total

1.  Combined Use of Astragalus Polysaccharide and Berberine Attenuates Insulin Resistance in IR-HepG2 Cells via Regulation of the Gluconeogenesis Signaling Pathway.

Authors:  Zhu-Jun Mao; Min Lin; Xin Zhang; Lu-Ping Qin
Journal:  Front Pharmacol       Date:  2019-12-23       Impact factor: 5.810

2.  miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF.

Authors:  Man Zhou; Yilin Hou; Jun Wu; Guangli Li; Ping Cao; Wan Chen; Lingli Hu; Dingyun Gan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.